← Leaderboards
Derek Raghavan
University Of Southern California
$1,863,220
Attributed
$1,863,220
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,863,220 · 4
By mechanism
U10$1,863,220 · 2
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Kathleen R Ell$9,983,182
- Louis Dubeau$6,576,174
- Veronica Wendy Setiawan$9,412,373
- Jeffrey N Weitzel$10,932,306
- Heinz Josef Lenz$20,123,312
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchNeoplasm /Cancer ChemotherapyHuman Therapy EvaluationHuman SubjectCombination ChemotherapyPaclitaxelCis Platinum CompoundBreast NeoplasmsAntineoplasticsCooperative StudyGastrointestinal NeoplasmsDoxorubicinBrain NeoplasmsHormone TherapyFemale Reproductive System NeoplasmBone Marrow TransplantationFludarabineCombination Cancer TherapyCancer PreventionCancer Information SystemCyclophosphamideCancer Registry /ResourceClinical TrialsBleomycin
Grant awards (13)
SOUTHWEST ONCOLOGY GROUP$51,074
U10 · FY2004 · CA
SOUTHWEST ONCOLOGY GROUP$201,061
U10 · FY2003 · CA
SOUTHWEST ONCOLOGY GROUP$75,000
U10 · FY2003 · CA
SOUTHWEST ONCOLOGY GROUP$333,200
U10 · FY2002 · CA
PHARMACOLOGY OF ANTICANCER DRUGS IN ADVANCED AGE$401,532
U10 · FY2001 · CA
SOUTHWEST ONCOLOGY GROUP$176,086
U10 · FY2001 · CA
SOUTHWEST ONCOLOGY GROUP$36,000
U10 · FY2001 · CA
PHARMACOLOGY OF ANTICANCER DRUGS IN ADVANCED AGE$417,902
U10 · FY2000 · CA
SOUTHWEST ONCOLOGY GROUP$171,365
U10 · FY2000 · CA
BRYOSTATIN IN COMBINATION W/ CISPLATIN IN CANCER PATIENTS$0
M01 · FY2000 · RR
GEMCITABINE &COMBINATION THERAPY IN UROTHELIAL CANCER$0
M01 · FY2000 · RR
GEMCITABINE &COMBINATION THERAPY IN UROTHELIAL CANCER$0
M01 · FY2000 · RR
BRYOSTATIN IN COMBINATION W/ CISPLATIN IN CANCER PATIENTS$0
M01 · FY2000 · RR